We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
- Authors
Todoroki, Yasuyuki; Kubo, Satoshi; Nakano, Kazuhisa; Miyazaki, Yusuke; Ueno, Masanobu; Satoh-Kanda, Yurie; Kanda, Ryuichiro; Miyagawa, Ippei; Hanami, Kentaro; Nakatsuka, Keisuke; Saito, Kazuyoshi; Nakayamada, Shingo; Tanaka, Yoshiya
- Abstract
Objective MCTD manifests with microvasculopathy and overlapping clinical features of SLE, SSc and idiopathic inflammatory myopathies (IIM). The aim of this study was to investigate the clinical significance of microvasculopathy in patients with MCTD using nailfold videocapillaroscopy (NVC). Methods Fifty patients with newly diagnosed and untreated MCTD were enrolled in this multicentre, prospective and observational study. Clinical features and NVC findings were assessed at baseline and after 1 year post-intervention, along with disease controls [SLE (n = 40), SSc (n = 70) and IIM (n = 50)]. Results All MCTD patients presented Raynaud's phenomenon and were positive for anti-U1 RNP antibodies, and 22.0% (11/50) had pulmonary arterial hypertension (PAH). The prevalence of NVC scleroderma patterns in MCTD was 38.0%, which was lower than SSc (88.6%) but higher than SLE (10.0%). In addition, when we divided MCTD patients into two groups by presence or absence of NVC scleroderma patterns, we found a higher prevalence of PAH in patients with NVC scleroderma patterns. Namely, NVC scleroderma patterns were observed in all MCTD patients with PAH, and in 21.0% of those without PAH. After intensive immunosuppressive therapy, NVC scleroderma patterns disappeared in half of the MCTD patients but were not changed in SSc patients. Conclusions MCTD differed from SLE, SSc and IIM in terms of the prevalence and responsiveness of NVC scleroderma patterns to immunosuppressive therapy. Detection of nailfold microvascular abnormalities in MCTD could contribute to predicting PAH and help us to understand further aspects of the pathogenesis of MCTD.
- Subjects
RESEARCH; RAYNAUD'S disease; AUTOANTIBODIES; SCIENTIFIC observation; DERMATOMYOSITIS; ANGIOSCOPY; SYSTEMIC scleroderma; IMMUNOSUPPRESSION; CONNECTIVE tissue diseases; DISEASE prevalence; DESCRIPTIVE statistics; SYSTEMIC lupus erythematosus; LONGITUDINAL method; DISEASE complications; SYMPTOMS
- Publication
Rheumatology, 2022, Vol 61, Issue 12, p4875
- ISSN
1462-0324
- Publication type
Article
- DOI
10.1093/rheumatology/keac165